• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity.局部用噻吗洛尔(0.5%)和倍他洛尔(0.5%)对角膜敏感性的影响。
Br J Ophthalmol. 1990 Jul;74(7):409-12. doi: 10.1136/bjo.74.7.409.
2
The effect of timolol, betaxolol, and placebo on corneal sensitivity in healthy volunteers.噻吗洛尔、倍他洛尔及安慰剂对健康志愿者角膜敏感性的影响。
J Ocul Pharmacol. 1990 Summer;6(2):85-90. doi: 10.1089/jop.1990.6.85.
3
Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial.盐酸倍他洛尔眼用混悬液0.25%与噻吗洛尔凝胶形成溶液0.25%和0.5%用于儿童青光眼:一项随机临床试验。
J AAPOS. 2009 Aug;13(4):384-90. doi: 10.1016/j.jaapos.2009.04.017.
4
[Corneal sensitivity after single doses of timolol, betaxolol or placebo in persons with healthy eyes--a randomized, prospective double-blind study].[健康眼睛人群单次使用噻吗洛尔、倍他洛尔或安慰剂后的角膜敏感性——一项随机、前瞻性双盲研究]
Fortschr Ophthalmol. 1988;85(2):132-8.
5
[Local anesthetic effect and subjective tolerance of 0.5% levobunolol in normal eyes].[0.5% 左布诺洛尔在正常眼的局部麻醉作用及主观耐受性]
Klin Monbl Augenheilkd. 1990 Jul;197(1):20-6.
6
Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
Age Ageing. 1996 Nov;25(6):424-8. doi: 10.1093/ageing/25.6.424.
7
[Local anesthetic effect and subjective tolerance of 2% carteolol and 0.6% metipranolol on healthy eyes].2% 卡替洛尔和 0.6% 美替洛尔对健康眼睛的局部麻醉作用及主观耐受性
Klin Monbl Augenheilkd. 1989 Apr;194(4):241-8.
8
Changes in depressive status associated with topical beta-blockers.与局部用β受体阻滞剂相关的抑郁状态变化。
Int Ophthalmol. 1992 Sep;16(4-5):331-5. doi: 10.1007/BF00917986.
9
Randomised, controlled trial of spirometric changes in elderly people receiving timolol or betaxolol as initial treatment for glaucoma.接受噻吗洛尔或倍他洛尔作为青光眼初始治疗的老年人肺活量变化的随机对照试验。
Br J Ophthalmol. 1998 Feb;82(2):146-9. doi: 10.1136/bjo.82.2.146.
10
The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects.噻吗洛尔和倍他洛尔局部滴眼对哮喘患者肺功能的影响。
Am Rev Respir Dis. 1986 Feb;133(2):264-8. doi: 10.1164/arrd.1986.133.2.264.

引用本文的文献

1
Neurotrophic Keratopathy in Marfan Syndrome Patient After Micropulse Transscleral Cyclophotocoagulation: A Call for Risk Stratification.马凡综合征患者行微脉冲经巩膜睫状体光凝术后发生神经营养性角膜病变:呼吁进行风险分层。
Am J Case Rep. 2024 Feb 22;25:e942538. doi: 10.12659/AJCR.942538.
2
A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications.抗青光眼药物相关眼表疾病的叙述性综述
Ophthalmol Ther. 2022 Oct;11(5):1681-1704. doi: 10.1007/s40123-022-00557-0. Epub 2022 Aug 9.
3
Long-term intraocular pressure after switching a combination ophthalmic medication of β-blocker/prostaglandin.更换β受体阻滞剂/前列腺素联合眼科药物后的长期眼压
Taiwan J Ophthalmol. 2020 Mar 5;10(2):95-99. doi: 10.4103/tjo.tjo_77_19. eCollection 2020 Apr-Jun.
4
Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.无防腐剂前列腺素类似物和前列腺素/噻吗洛尔固定组合治疗青光眼:疗效、安全性和潜在优势。
Drugs. 2018 Jan;78(1):39-64. doi: 10.1007/s40265-017-0843-9.
5
Long-term Follow-up of Patients receiving Intraocular Pressure-lowering Medications as Cataract Surgery Candidates: A Case-control Study.接受降眼压药物治疗的白内障手术候选患者的长期随访:一项病例对照研究。
J Curr Glaucoma Pract. 2017 Sep-Dec;11(3):107-112. doi: 10.5005/jp-journals-10028-1234. Epub 2017 Oct 27.
6
The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study.从拉坦前列素转换为他氟前列素/噻吗洛尔固定复方制剂后眼表疾病的体征:一项前瞻性研究。
Clin Ophthalmol. 2017 Jun 21;11:1175-1181. doi: 10.2147/OPTH.S136418. eCollection 2017.
7
Congenital Corneal Anesthesia and Neurotrophic Keratitis: Diagnosis and Management.先天性角膜麻醉与神经营养性角膜炎:诊断与治疗
Biomed Res Int. 2015;2015:805876. doi: 10.1155/2015/805876. Epub 2015 Sep 16.
8
Conjunctival and corneal sensitivity in patients under topical antiglaucoma treatment.局部抗青光眼治疗患者的结膜和角膜敏感性
Int Ophthalmol. 2016 Jun;36(3):299-303. doi: 10.1007/s10792-015-0115-1. Epub 2015 Aug 14.
9
The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients.瑞巴派特对青光眼患者中拉坦前列素和噻吗洛尔所致眼表疾病的影响。
J Ophthalmol. 2015;2015:689076. doi: 10.1155/2015/689076. Epub 2015 May 10.
10
Decreased corneal sensitivity and abnormal corneal nerves in Fuchs endothelial dystrophy.Fuchs 内皮营养不良患者角膜敏感性降低和角膜神经异常。
Cornea. 2012 Nov;31(11):1257-63. doi: 10.1097/ICO.0b013e31823f7888.

本文引用的文献

1
A HISTOCHEMICAL STUDY OF THE ADRENERGIC AND CHOLINERGIC INNERVATION OF THE ANTERIOR SEGMENT OF THE RABBIT EYE.兔眼前节肾上腺素能和胆碱能神经支配的组织化学研究
Invest Ophthalmol. 1964 Dec;3:592-600.
2
Adverse reactions from timolol administration.噻吗洛尔给药引起的不良反应。
Ophthalmology. 1980 May;87(5):447-50. doi: 10.1016/s0161-6420(80)35215-9.
3
Corneal anaesthesia after topical treatment with timolol maleate. A case report.用马来酸噻吗洛尔局部治疗后的角膜麻醉。病例报告。
Acta Ophthalmol (Copenh). 1981 Jun;59(3):347-9. doi: 10.1111/j.1755-3768.1981.tb02999.x.
4
Use of betaxolol in the reduction of elevated intraocular pressure.倍他洛尔在降低眼压升高中的应用。
Arch Ophthalmol. 1983 Jun;101(6):898-900. doi: 10.1001/archopht.1983.01040010898008.
5
Effects of topical betaxolol in ocular hypertensive patients.局部用倍他洛尔对高眼压症患者的影响。
Arch Ophthalmol. 1984 Apr;102(4):539-40. doi: 10.1001/archopht.1984.01040030417014.
6
Short-term and long-term timolol maleate effects on corneal sensitivity.
Doc Ophthalmol. 1984 Feb 29;56(4):385-92. doi: 10.1007/BF00155683.
7
Betaxolol and timolol. A comparison of efficacy and side effects.倍他洛尔与噻吗洛尔。疗效及副作用比较。
Arch Ophthalmol. 1984 Jan;102(1):42-5. doi: 10.1001/archopht.1984.01040030026028.
8
The occurrence of serotonergic nerves in the bovine cornea.牛角膜中5-羟色胺能神经的存在。
Neurosci Lett. 1983 Jan 31;35(1):15-8. doi: 10.1016/0304-3940(83)90519-0.
9
Dopamine modulation of active ion transport in rabbit corneal epithelium.
Invest Ophthalmol Vis Sci. 1984 Nov;25(11):1240-5.
10
Substance P-immunoreactive nerves in the human cornea and iris.人角膜和虹膜中P物质免疫反应性神经
Invest Ophthalmol Vis Sci. 1982 Nov;23(5):671-4.

局部用噻吗洛尔(0.5%)和倍他洛尔(0.5%)对角膜敏感性的影响。

Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity.

作者信息

Weissman S S, Asbell P A

机构信息

Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY.

出版信息

Br J Ophthalmol. 1990 Jul;74(7):409-12. doi: 10.1136/bjo.74.7.409.

DOI:10.1136/bjo.74.7.409
PMID:2378856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1042150/
Abstract

There are conflicting reports on the propensity of topical beta blockers to produce corneal anaesthesia. We measured corneal sensitivity thresholds quantitatively for 10 minutes following the administration of one drop of topical timolol maleate (0.5%), betaxolol hydrochloride (0.5%), or saline in 30 eyes of 18 normal subjects in a randomised, double-masked study. Most subjects had insignificant changes in corneal sensitivity thresholds. We identified, however, a subgroup of four subjects (five eyes) that had a marked and prolonged increase of corneal sensitivity threshold (corneal anaesthesia) after timolol (three eyes) and betaxolol (two eyes). The group mean age of these 'responders' (49.0 years) was significantly greater (p less than 0.005) than that of the non-responders (35.0). We recommend periodic measurements of corneal sensitivity in older patients receiving topical timolol or betaxolol, especially when given in higher concentrations, to identify responders, who may be at risk of developing keratitis.

摘要

关于局部用β受体阻滞剂产生角膜麻醉的倾向,存在相互矛盾的报道。在一项随机、双盲研究中,我们对18名正常受试者的30只眼睛滴入一滴局部用马来酸噻吗洛尔(0.5%)、盐酸倍他洛尔(0.5%)或生理盐水后,定量测量了10分钟内的角膜敏感性阈值。大多数受试者的角膜敏感性阈值变化不明显。然而,我们确定了一个由四名受试者(五只眼睛)组成的亚组,他们在使用噻吗洛尔(三只眼睛)和倍他洛尔(两只眼睛)后,角膜敏感性阈值出现了显著且持续的升高(角膜麻醉)。这些“反应者”的平均年龄(49.0岁)显著高于无反应者(35.0岁)(p<0.005)。我们建议对接受局部用噻吗洛尔或倍他洛尔治疗的老年患者定期测量角膜敏感性,尤其是在使用较高浓度药物时,以识别可能有发生角膜炎风险的反应者。